Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hinrich P Hansen

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|April 17, 2020
Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin LymphomaHinrich P Hansen, Adriana F Paes Leme, Michael Hallek
Annals of Translational Medicine|December 24, 2015
NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cellsElke Pogge von Strandmann, Olga Shatnyeva, Hinrich P Hansen
Advances in Experimental Medicine and Biology|July 4, 2026
Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal CellsThaís Dolzany de Oliveira, Prerana Wagle, Hinrich P Hansen
Analytical Biochemistry|May 15, 2016
An improved fluorescent substrate for assaying soluble and membrane-associated ADAM family member activitiesMarcia L Moss, Dmitriy Minond, Toshie Yoneyama, et al.
Transplant Immunology|July 13, 2010
A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantationKai Hübel, Birgit Cremer, Eva Heuser, et al.
Haematologica|May 10, 2007
Simvastatin-dependent apoptosis in Hodgkin's lymphoma cells and growth impairment of human Hodgkin's tumors in vivoBastian von Tresckow, Elke Pogge von Strandmann, Stephanie Sasse, et al.
Biological Chemistry|June 22, 2013
Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitroMaike Sauer, Katrin S Reiners, Hinrich P Hansen, et al.
Acta Dermato-Venereologica|October 4, 2002
Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitisRegina Fölster-Holst, Tilo Henseler, Jörg Wehde, et al.
Journal of Molecular Recognition : JMR|January 31, 2003
Human CD30: structural implications from epitope mapping and modeling studiesLiying Dong, Martin Hülsmeyer, Horst Dürkop, et al.
Frontiers in Genetics|February 21, 2015
DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapiesOlga M Shatnyeva, Hinrich P Hansen, Katrin S Reiners, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|April 17, 2020
Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin LymphomaHinrich P Hansen, Adriana F Paes Leme, Michael Hallek
Annals of Translational Medicine|December 24, 2015
NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cellsElke Pogge von Strandmann, Olga Shatnyeva, Hinrich P Hansen
Advances in Experimental Medicine and Biology|July 4, 2026
Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal CellsThaís Dolzany de Oliveira, Prerana Wagle, Hinrich P Hansen
Analytical Biochemistry|May 15, 2016
An improved fluorescent substrate for assaying soluble and membrane-associated ADAM family member activitiesMarcia L Moss, Dmitriy Minond, Toshie Yoneyama, et al.
Transplant Immunology|July 13, 2010
A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantationKai Hübel, Birgit Cremer, Eva Heuser, et al.
Haematologica|May 10, 2007
Simvastatin-dependent apoptosis in Hodgkin's lymphoma cells and growth impairment of human Hodgkin's tumors in vivoBastian von Tresckow, Elke Pogge von Strandmann, Stephanie Sasse, et al.
Biological Chemistry|June 22, 2013
Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitroMaike Sauer, Katrin S Reiners, Hinrich P Hansen, et al.
Acta Dermato-Venereologica|October 4, 2002
Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitisRegina Fölster-Holst, Tilo Henseler, Jörg Wehde, et al.
Journal of Molecular Recognition : JMR|January 31, 2003
Human CD30: structural implications from epitope mapping and modeling studiesLiying Dong, Martin Hülsmeyer, Horst Dürkop, et al.
Frontiers in Genetics|February 21, 2015
DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapiesOlga M Shatnyeva, Hinrich P Hansen, Katrin S Reiners, et al.
Pageof 5